does pfizer make glp 1 dips on new data for obesity drug acquired in $10B deal Pfizer Acquires a GLP-1 Pipeline
Description
A major new study reveals that women who discontinued these medications gained over 3 kg more during pregnancy compared to those who never used them
12 month program to help employees manage their weight, now with GLP-1 support
Aetna coverage for Saxenda varies by plan and may require prior authorization
The China Center for Drug Evaluation (CDE) announced that Shiling Pharma's semaglutide nasal spray has been approved for clinical trials for long-term weight management in adults (obese and overweight)
